心脏移植:它仍然是黄金标准吗?
Tania Kakoudaki1, Sri Aurovind1, Anna Kydd1
1Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
British journal of hospital medicine (London, England : 2005)
|December 24, 2025
概括
心脏移植 (HT) 是高级心力衰竭 (AHF) 的黄金标准,但通过左心室辅助装置 (LVAD) 的机械循环支持提供了一个重要的替代方案. 虽然HT的存活率更高,但捐赠器官稀缺性影响了其广泛使用.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 医疗技术 医疗技术 医学技术
背景情况:
- 晚期心力衰竭 (AHF) 在患者预后不佳的情况下带来了重大挑战.
- 手术干预,包括机械循环支持 (MCS) 和心脏移植 (HT),已经推进了AHF治疗.
- 左心室辅助器械 (LVAD) 治疗是选择AHF患者HT的关键替代方案.
研究的目的:
- 为了比较心脏移植 (HT) 与左心室辅助器件 (LVAD) 治疗晚期心力衰竭 (AHF) 的疗效和局限性.
- 对两种治疗方式的当前生存率和生活质量考虑进行审查.
- 讨论MCS的未来方向和AHF管理的捐助者战略.
主要方法:
- 对HT和当代LVADs的生存数据的比较分析.
- 对生活质量结果和与设备相关的并发症的审查.
- 讨论捐赠器官的可用性和新兴的LVAD技术.
主要成果:
- 在HT后的5年生存率为72%,而当代LVAD的58-63%.
- HT提供了更好的生活质量,并避免了与设备相关的并发症.
- 供体器官的可用性仍然是HT的重大限制.
结论:
- 心脏移植是精心挑选的AHF患者的黄金标准,提供更高的存活率和生活质量.
- LVAD疗法是一个重要的和不断发展的替代方案,特别是当捐赠器官无法使用时.
- 完全植入的LVAD和扩展的捐赠者策略的未来进展对于优化AHF治疗至关重要.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
01:30Cardiomyopathy II: Dilated Cardiomyopathy
431
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
01:22Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
360
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
01:28Kidney Transplant I: Introduction
304
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
304